GE HealthCare has dosed the first patient in its Phase II/III LUMINA clinical trial for the investigational manganese-based MRI contrast agent, mangaciclanol.
Eurofins Scientific SE (the "Company") (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.
The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with ...
AI delivers fast network gains, yet full autonomy remains limited by trust and accountability concerns.
Why leading AI companies, Fortune 500 enterprises, and high-growth tech startups are choosing the Philippines as their ...
5hon MSN
Label-free optical imaging enables automated measurement of human white matter microstructure
White matter pathways allow distant parts of the brain to communicate, supporting memory, emotion, and language. One such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results